Cingulate Therapeutics

1 follower


Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.

Industries

Employees

11-50

Links


Org chart

Shane J. Schaffer
Chairman & CEO
Collapse
Raul R. Silva
Chief Science Officer
Matthew Brams
Chief Medical Officer
Arthur Straughn
Co-founder Board of Directors
Naama Courtemanche
Vp, Operations And Quality Assurance
Thomas Dalton
Vice President, Investor & Public Relations; Vice President, Government Affairs
Jennifer Callahan
Svp, Chief Financial Officer

Board & advisors